Schambye Hans T.
- SEC CIK
- 0001825776
In the past year, 1 open-market sale filing worth $15.0K and no purchases.
Current role at each company
- DMRA Damora Therapeutics, Inc.Chief Executive Officeras of Jan 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $15.0K
- 1 filing
- Net
- −$15.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Schambye Hans T. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Schambye Hans T.Chief Executive Officer | SSale | −700 | $21.38 | −$15.0K | −13.0%4.68K after | |
| Jul 8, 2025 (view filing) | Jul 3 | 5 days | Schambye Hans T.Chief Executive Officer | SSale | −735 | $3.38 | −$2.48K | −15.5%4.02K after | |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Schambye Hans T.Chief Executive Officer | SSale | −1.34K | $5.60 | −$7.51K | −28.3%3.40K after | |
| Mar 23, 2022 (view filing) | Mar 22 | 1 day | Schambye Hans T.Chief Executive Officer | PPurchase | +5.00K | $2.15 | +$10.8K | +10.5%52.4K after | |
| Nov 10, 2021 (view filing) | Nov 9 | 1 day | Schambye Hans T.Chief Executive Officer | PPurchase | +4.50K | $3.50 | +$15.8K | +10.5%47.4K after |